Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Select Medical Holdings (SEM) Dividends Paid - Common (2018 - 2025)

Select Medical Holdings (SEM) has disclosed Dividends Paid - Common for 7 consecutive years, with $66.2 million as the latest value for Q4 2025.

  • On a quarterly basis, Dividends Paid - Common rose 173.53% to $66.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $89.9 million, a 21.58% increase, with the full-year FY2025 number at $89.9 million, up 49.8% from a year prior.
  • Dividends Paid - Common was $66.2 million for Q4 2025 at Select Medical Holdings, up from $7.7 million in the prior quarter.
  • In the past five years, Dividends Paid - Common ranged from a high of $66.2 million in Q4 2025 to a low of $7.7 million in Q3 2025.
  • A 5-year average of $19.2 million and a median of $16.0 million in 2023 define the central range for Dividends Paid - Common.
  • Peak YoY movement for Dividends Paid - Common: surged 277.8% in 2021, then tumbled 59.51% in 2022.
  • Select Medical Holdings' Dividends Paid - Common stood at $39.3 million in 2021, then crashed by 59.51% to $15.9 million in 2022, then grew by 0.95% to $16.0 million in 2023, then soared by 50.8% to $24.2 million in 2024, then skyrocketed by 173.53% to $66.2 million in 2025.
  • Per Business Quant, the three most recent readings for SEM's Dividends Paid - Common are $66.2 million (Q4 2025), $7.7 million (Q3 2025), and $7.9 million (Q2 2025).